Discovery and reporting of clinically-relevant germline variants in advanced cancer patients assessed using whole-exome sequencing
Tuo Zhang, Alessandro Romanel, Kenneth Eng, Hanna Rennert, Adrian Y. Tan, Yaohua Xue, Joanna Cyrta, Juan Miguel Mosquera, Andrea Sboner, Ivan H. Iossifov, Steven M. Lipkin, Jenny Xiang, Xiaojun Feng, Peter S. Nelson, Himisha Beltran, , Olivier Elemento
This study reports that 17% of advanced cancer patients have clinically relevant germline variants, with higher rates of cancer-associated variants compared to control cohorts.
bioRxiv · Mar 1, 2017 · PreprintGenomics